Standout Papers

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer 2021 2026 2022 2024416
  1. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer (2021)
    Yelena Y. Janjigian, Akihito Kawazoe et al. Nature

Immediate Impact

4 by Nobel laureates 12 from Science/Nature 59 standout
Sub-graph 1 of 21

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
1 intermediate paper

Works of Yong Tang being referenced

<p>MDM2 promotes epithelial&ndash;mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma</p>
2019
Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
2011

Author Peers

Author Last Decade Papers Cites
Yong Tang 479 756 615 61 1.7k
Yasushi Kasai 427 720 1087 64 2.1k
Tsutomu Iwasa 526 750 449 82 1.4k
Niranjan Awasthi 287 690 873 65 1.9k
Yong Wha Moon 659 890 639 68 1.8k
Tobias Dechow 453 776 677 71 2.0k
Bunzo Nakata 414 1014 558 75 1.7k
Michael Allgäuer 770 747 420 62 1.8k
Charles LeVea 314 976 709 69 1.7k
Raffael Kurek 715 1000 954 38 2.2k
Chun‐Kui Shao 256 785 630 75 1.7k

All Works

Loading papers...

Rankless by CCL
2026